Publicacións nas que colabora con MARÍA DOLORES FOLGUEIRA LÓPEZ (11)

2023

  1. Clinical outcomes and antibody transfer in a cohort of infants with in utero or perinatal exposure to SARS-CoV-2 (Coronascope Study)

    European Journal of Pediatrics, Vol. 182, Núm. 10, pp. 4647-4654

  2. Cross neutralization of SARS-CoV-2 omicron subvariants after repeated doses of COVID-19 mRNA vaccines

    Journal of Medical Virology, Vol. 95, Núm. 1

  3. Superior neutralizing response after first versus second SARS-CoV-2 infection in fully vaccinated individuals

    Journal of Medical Virology, Vol. 95, Núm. 11

2022

  1. Clinical presentation and virological assessment of confirmed human monkeypox virus cases in Spain: a prospective observational cohort study

    The Lancet, Vol. 400, Núm. 10353, pp. 661-669

  2. Neutralizing Response Against SARS-CoV-2 Variants 8 Months After BNT162b2 Vaccination in Naive and COVID-19-Convalescent Individuals

    The Journal of infectious diseases, Vol. 225, Núm. 11, pp. 1905-1908

  3. Viruses and Mycoplasma pneumoniae are the main etiological agents of community-acquired pneumonia in hospitalized pediatric patients in Spain

    Pediatric pulmonology, Vol. 57, Núm. 1, pp. 253-263

2021

  1. Prime-boost vaccination with BNT162b2 induces high neutralizing activity against SARS-CoV-2 variants in naïve and COVID-19-convalescent individuals

    Open Forum Infectious Diseases, Vol. 8, Núm. 10

  2. Prolonged SARS-CoV-2 cell culture replication in respiratory samples from patients with severe COVID-19

    Clinical Microbiology and Infection, Vol. 27, Núm. 6, pp. 886-891

  3. Severe Acute Respiratory Syndrome Coronavirus 2 Vertical Transmission from an Asymptomatic Mother

    The Pediatric infectious disease journal, Vol. 40, Núm. 3, pp. e115-e117

2020

  1. Prevalence and Clinical Manifestations of Congenital Cytomegalovirus Infection in a Screening Program in Madrid (PICCSA Study)

    Pediatric Infectious Disease Journal, Vol. 39, Núm. 11, pp. 1050-1056

  2. Seroprevalence analysis of SARS-CoV-2 in pregnant women along the first pandemic outbreak and perinatal outcome

    PLoS ONE, Vol. 15, Núm. 11 November 2020